By Drug Target Review2024-04-15T15:00:35
The new findings could lead to new therapeutics and a method to diagnose pancreatic cancer earlier, improving its prognosis.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud